Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle
Overview
Authors
Affiliations
In vivo reprogramming is a promising approach for tissue regeneration in response to injury. Several examples of in vivo reprogramming have been reported in a variety of lineages, but some including skeletal muscle have so far proven refractory. Here, we show that acute and chronic injury enables transcription-factor-mediated reprogramming in skeletal muscle. Lineage tracing indicates that this response frequently originates from Pax7+ muscle stem cells. Injury is associated with accumulation of senescent cells, and advanced aging or local irradiation further enhanced in vivo reprogramming, while selective elimination of senescent cells reduced reprogramming efficiency. The effect of senescence appears to be, at least in part, due to the release of interleukin 6 (IL-6), suggesting a potential link with the senescence-associated secretory phenotype. Collectively, our findings highlight a beneficial paracrine effect of injury-induced senescence on cellular plasticity, which will be important for devising strategies for reprogramming-based tissue repair.
Rahbar Saadat Y, Abbasi A, Hejazian S, Hekmatshoar Y, Ardalan M, Farnood F BMC Nephrol. 2025; 26(1):133.
PMID: 40069669 PMC: 11895341. DOI: 10.1186/s12882-025-04057-8.
Senescent-like microglia limit remyelination through the senescence associated secretory phenotype.
Gross P, Duran-Laforet V, Ho L, Melchor G, Zia S, Manavi Z Nat Commun. 2025; 16(1):2283.
PMID: 40055369 PMC: 11889183. DOI: 10.1038/s41467-025-57632-w.
Zare E, Hosseini E, Azad F, Javid A, Javazm R, Abessi P Histochem Cell Biol. 2025; 163(1):34.
PMID: 40042688 DOI: 10.1007/s00418-025-02364-7.
Metabolic regulation in adult and aging skeletal muscle stem cells.
Sartorelli V, Ciuffoli V Genes Dev. 2024; 39(3-4):186-208.
PMID: 39662967 PMC: 11789647. DOI: 10.1101/gad.352277.124.
Cellular senescence and SASP in tumor progression and therapeutic opportunities.
Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F Mol Cancer. 2024; 23(1):181.
PMID: 39217404 PMC: 11365203. DOI: 10.1186/s12943-024-02096-7.